Eupraxia Pharmaceuticals Financial Overview
Eupraxia Pharmaceuticals's market cap is currently C$375.21M. The company's EPS TTM is $-0.19425202800000002; its P/E ratio is -8.45; Eupraxia Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
